NCT04993742 (MOMSPlacenta) is a NA clinical trial of MOMS Intervention in Placental Dysfunction, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

Who is sponsoring NCT04993742?

NCT04993742 is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.

What drugs are being tested in NCT04993742?

Interventions in NCT04993742: MOMS Intervention.

What condition does NCT04993742 study?

NCT04993742 studies Placental Dysfunction, Prenatal Stress.

Is NCT04993742 still recruiting?

NCT04993742 is currently active, enrolled. Last updated 12 February 2026.

Last reviewed 2026-02-12 · How we verify

NCT04993742: MOMSPlacenta

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative Stress Response and Birth Outcomes

Active, enrolled NA Last updated 12 February 2026

What this trial tests

NA trial testing MOMS Intervention in Placental Dysfunction in 150 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

26 November 2019

Primary endpoint
30 September 2026

31 December 2026

Quick facts

Lead sponsor	Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	150
Start date	26 November 2019
Primary completion	30 September 2026
Estimated completion	31 December 2026
Sites	1 location across United States

Drugs / interventions tested

MOMS Intervention

Conditions studied

Placental Dysfunction — all drugs for Placental Dysfunction →
Prenatal Stress — all drugs for Prenatal Stress →

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Who can join

18 and older, female only, with Placental Dysfunction or Prenatal Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Explore the associations of prenatal maternal anxiety to placental histologic findings, and the pro-inflammatory, anti-inflammatory, and immunoregulatory cells found in the placenta and determine the effect of maternal anxiety on the association between placental molecular changes on pregnancy and birth and infant outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Henry M. Jackson Foundation for the Advancement of Military Medicine trials

Trials by the same sponsor.

NCT07249762 — Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robu · not yet recruiting
NCT07223684 — TDAP in Burn Patients (Group 2) · not yet recruiting
NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
NCT06885554 — Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation · NA · recruiting
NCT06855186 — Symptom-Targeted Approach to Rehabilitation for Concussion (STAR-C) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04993742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Henry M. Jackson Foundation for the Advancement of Military Medicine
Last refreshed: 12 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04993742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing